Protecting Axons
Protecting Patients
Creating breakthrough therapeutics for neurological diseases
Disarm Therapeutics is a wholly owned subsidiary of Eli Lilly and Company

February 24, 2020
publication
+
Creating breakthrough therapeutics for neurological diseases
Disarm Therapeutics is a wholly owned subsidiary of Eli Lilly and Company
February 24, 2020
publication